| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
KH MA MD TN |
| (30) |
Priority: |
16.08.2022 US 202217889285
16.08.2022 US 202263398494 P
|
| (71) |
Applicant: Oyster Point Pharma, Inc. |
|
Princeton, New Jersey 08540 (US) |
|
| (72) |
Inventors: |
|
- LOKHNAUTH, John K.
Princeton, NJ 08540 (US)
- EHRNSPERGER, Eric C.
Princeton, NJ 08540 (US)
- BUEL, Travis D.
Hickman, NE 68372 (US)
- LEPREE, Jason M.
Demarest, NJ 07627 (US)
- DONATO, George J.
Princeton, NJ 08540 (US)
- NAU, Jeffrey Alan
Princeton, NJ 08540 (US)
- SMITH, Peter A.
Cary, NC 27518 (US)
- RANALLETTA, Joseph Vincent
Greenville, SC 29601 (US)
- NICHOLS, Eli B.
Jacksonville, FL 32226 (US)
|
| (74) |
Representative: Gill Jennings & Every LLP |
|
The Broadgate Tower
20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB) |
|
